ReviewExperimental & molecular medicine2022

The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era.

Eunjin Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.